October 24, 2016 3:07 PM ET


Company Overview of Nabi Biopharmaceuticals Inc.

Company Overview

As of October 30, 2012, Nabi Biopharmaceuticals Inc. was acquired by Biota Pharmaceuticals, Inc., in a reverse merger transaction. Nabi Biopharmaceuticals Inc. develops vaccines for unmet medical needs including nicotine addiction. The company develops NicVAX, a proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. The company was formerly known as North American Biologicals, Inc. and changed its name to Nabi Biopharmaceuticals Inc. in 1996. Nabi Biopharmaceuticals Inc. was founded in 1967 and is headquartered in Rockville, Maryland.

12276 Wilkins Avenue

Rockville, MD 20852

United States

Founded in 1967

16 Employees





Key Executives for Nabi Biopharmaceuticals Inc.

Nabi Biopharmaceuticals Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nabi Biopharmaceuticals Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.